Neue Novavax: Anstieg nach 1:20 Re-Split


Seite 1 von 14
Neuester Beitrag: 25.09.20 15:16
Eröffnet am: 15.05.19 08:23 von: moneywork4. Anzahl Beiträge: 346
Neuester Beitrag: 25.09.20 15:16 von: Banani Leser gesamt: 47.863
Forum: Hot-Stocks   Leser heute: 36
Bewertet mit:
3


 
Seite: < 1 | 2 | 3 | 4 |
12 | 13 | 14 14  >  

522 Postings, 514 Tage moneywork4meNeue Novavax: Anstieg nach 1:20 Re-Split

 
  
    #1
3
15.05.19 08:23
Bemerkenswerter Anstieg nach dem Re-Split 1:20
7,13USD        +1,37USD     +23,78% mit entsprechendem Volumen:

Volumen (Stück) 1.262.067

Die Amis sprechen von Schnäppchenjäger
https://seekingalpha.com/news/...gain-hunters-jump-novavax-28-percent

About

https://novavax.com/  
320 Postings ausgeblendet.
Seite: < 1 | 2 | 3 | 4 |
12 | 13 | 14 14  >  

600 Postings, 562 Tage BananiNEJM Publication der Phase 1 Data

 
  
    #322
03.09.20 06:30
Novavax Announces Publication of Phase 1 Data for COVID-19 Vaccine Candidate in The New England Journal of Medicine

https://ir.novavax.com/news-releases/...phase-1-data-covid-19-vaccine


Link zum NEJM:

https://www.nejm.org/doi/full/10.1056/...0?query=featured_coronavirus  

3923 Postings, 5009 Tage Excellenceim heutigen Bericht, beste 3 Aktien der Zukunft

 
  
    #323
1
04.09.20 09:55
wird Novavax als die aussichtsreichste der Covid19 Kanidaten erwähnt.
Novavax wird sie alle schlage und das Rennen machen.  

3923 Postings, 5009 Tage ExcellenceKeith Speights, Motley Fool beitragender Investmen

 
  
    #324
04.09.20 10:33
1. Novavax

Die Aktien von Novavax (WKN: A2PKMZ) sind bisher um fast 3.400 % gestiegen. Und das soll sich noch einmal verdoppeln können? Das ist durchaus denkbar.

Die beeindruckende Performance von Novavax ist auf zwei wichtige Entwicklungen zurückzuführen. Im März berichtete das Unternehmen über sehr gute Ergebnisse einer Studie im Spätstadium von NanoFlu. Das schuf die Voraussetzungen für die Einreichung eines Zulassungsantrags bei der Food and Drug Administration. Novavax gab Anfang August auch positive Ergebnisse einer Phase-1-Studie mit dem neuartigen Coronavirus-Impfstoffkandidaten NVX-CoV2373 bekannt.

Trotz des enormen Zuwachses seit Jahresbeginn liegt die Marktkapitalisierung von Novavax unter 9 Milliarden US-Dollar. Das ist nur etwa ein Drittel der Marktkapitalisierung von Moderna (WKN:A2N9D9). Dabei handelt es sich um ein Biotech-Unternehmen, das Novavax mit einem COVID-19-Impfstoffkandidaten, der sich bereits in Phase-3-Tests befindet, voraus ist.

Der Trick für die Verdoppelung der Novavax-Aktie bis zum Jahresende besteht darin, dass das Unternehmen mit seinen Phase-2-Studien von NVX-CoV2373 begeistert und den experimentellen Impfstoff in die Spätphase der Erprobung bringt. Novavax hat bereits mit einer Phase-2-Studie des Kandidaten in Südafrika begonnen und will demnächst mit Studien in den USA und Australien beginnen. Moderna hat etwa zwei Monate nach Beginn der Phase-2-Studie mit einer Phase-3-Studie für seinen Impfstoffkandidaten begonnen. Wenn Novavax einem ähnlichen Zeitplan folgt und NVX-CoV2373 sein Potenzial voll ausschöpft, könnten sich die Aktien des Biotech-Unternehmens bis Ende 2020 mindestens verdoppeln.

2. Inovio Pharmaceuticals

Die Aktien von Inovio Pharmaceuticals (WKN: A115GK) stiegen bis Ende Juni um fast 850 % im bisherigen Jahresverlauf. Seitdem ist die Aktie zwar wieder ein wenig gesunken, aber in diesem Jahr bisher immer noch um fast 330 % gestiegen. Inovio müsste auf den Wert von vor zwei Monaten zurückkehren, um seinen Wert zu verdoppeln. Das scheint keine allzu große Aufgabe zu sein.
 

3923 Postings, 5009 Tage ExcellenceEr spricht von einer

 
  
    #325
04.09.20 10:35
mindestens verdopplung bis 12/2020  
Lassen wir uns überraschen  

600 Postings, 562 Tage BananiSeeking Alpha - Edmund Ingham

 
  
    #326
04.09.20 11:07
Novavax: Reasons To Believe Company Will Deliver Best-In-Class COVID-19 Vaccine
(Seeking Alpha - Edmund Ingham)

Summary:

Novavax's share price has risen from $4, to $181 in 2020, and is now in decline, trading at $99.7 at the time of writing.

The company's promising SARS-Cov-2 vaccine has produced some of the most positive data to date, and Novavax has secured ~$2bn in development funding.

I put the share price decline down to the recent progress of treatments developed by pharmas GSK, AZN, and PFE, plus less favourable treatment from Operation Warp Speed.

I believe Novavax can secure approval for its COVID-19 vaccine, given its learnings from developing 2 late-stage vaccines for RSV and Flu, and expect to see its shares trade above $160 before the end of the year.

The longer-term downside case is severe, despite the RSV and flu opportunities, but I would not expect to see NVAX drop below $80 in 2020.

https://seekingalpha.com/article/...st-in-class-covidminus-19-vaccine  

600 Postings, 562 Tage BananiBarrons Artikel

 
  
    #327
04.09.20 12:24
Novavax Stock Is Jumping Again on Positive New Data on Its Covid-19 Vaccine

... The Novavax vaccine is a relatively more proven approach compared with the more cutting-edge approaches employed by vaccines already in U.S. Phase 3 trials from AstraZeneca (AZN), Moderna (MRNA), and Pfizer (PFE). A flu vaccine under development by Novavax that uses the same technology succeeded in a Phase 3 trial in March.

GlaxoSmithKline (GSK) and Sanofi (SNY) are using an approach similar to that of Novavax in the Covid-19 vaccine they are jointly developing, but the companies aren’t as far along. They announced Thursday the start of their first in-human Phase 1 trial...

https://www.barrons.com/amp/articles/...-covid-19-vaccine-51599139151  

600 Postings, 562 Tage BananiFDA Commissioner Stephen Hahn and Novavax,

 
  
    #328
04.09.20 18:54
FDA Commissioner Stephen Hahn and Novavax, Inc.'s Stanley Erck

The Economic Club of Washington, D.C. will host a virtual Signature Event on Thursday, September 10, 2020 from 12:00 p.m. to 1:00 p.m. EDT. David Rubenstein will interview The Honorable Stephen M. Hahn, M.D., Commissioner of Food and Drugs of the Food and Drug Administration and Stanley C. Erck, President and Chief Executive Officer of Novavax, Inc. to discuss, among other things, the overall effects of the pandemic, the progression of vaccines and therapeutics, and the way forward.


https://www.economicclub.org/events/...-and-novavax-incs-stanley-erck  

600 Postings, 562 Tage BananiThe European Commission...

 
  
    #329
04.09.20 22:05
The European Commission is in discussions with Novavax to add the company's COVID-19 vaccine candidate to its shopping list, Politico's Sarah Wheaton reports. Novavax's potential vaccine would be the 7th candidate for procurement from the EU, Wheaton notes.

https://thefly.com/n.php?id=3156417  

600 Postings, 562 Tage Banani... Could Be Available by Year-End

 
  
    #330
05.09.20 10:42
A Coronavirus Vaccine, or Three, Could Be Available by Year-End

... Overall, we see probabilities of approval of 50%-70% for the leading programs--from Moderna, Pfizer/BioNTech, Astra/Oxford, and Novavax (NVAX)--with variation due to neutralizing antibody efficacy. Novavax’s efficacy looks the strongest, in our opinion, while Astra’s weaker preclinical data and tougher comparisons to convalescent sera in phase 1 could give it a slightly weaker probability of reaching efficacy thresholds in phase 3. Importantly, these four vaccines represent three different platforms, which we think should reduce any correlation between failure or success...

... Novavax phase 1 data was strong, and the very low dosage required could give the firm the ability to produce large supply of an antigen-based vaccine. This could be the first vaccine approved that uses a more established vaccine technology (as opposed to mRNA and viral vector technologies with other leading vaccine programs)...


https://www.morningstar.com/articles/1000541/...available-by-year-end  

600 Postings, 562 Tage BananiBiopharma Leaders Unite to Stand with Science

 
  
    #331
08.09.20 12:46
-- Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines --

https://ir.novavax.com/news-releases/...a-leaders-unite-stand-science  

600 Postings, 562 Tage BananiHier ein aktueller Tschechischer

 
  
    #332
08.09.20 16:48
Artikel auf Englisch übersetzt:

https://www.ozdravotnictvi.cz/rozhovory/...viru-u-prahy-je-prioritou/


New CZ article:
(Google translation from CZ - EN)

Novavax recently purchased the Prague Vaccines production plant in Bohumil in the Prague-East district. He intends to produce the coronavirus vaccine he is currently developing here. We asked Stanley Erck, CEO and President of Novavax, for details.

In addition to the already announced production of coronavirus vaccines, is the production of vaccines against other diseases planned in the Czech Republic?

The coronavirus vaccine is currently a priority for us in Czech production. We are working so that it can be prepared and approved as soon as possible. Our main goal now is to supply a functional vaccine to the market in an adequate amount, which is up to 1 billion doses of NVX-CoV2373, our COVID-19 vaccine, per year during the full operation of our Czech plant.

Of course, Novavax is also working on the development of other vaccines, and we are currently furthest with the development of NanoFlu, our influenza vaccine, which has shown positive results in the third phase of testing. After overcoming the current pandemic, we also plan to fully return to the production of a seasonal flu vaccine, which we will fully devote to the Czech plant near Prague. In other branches of Novavax, we also work on, for example, a vaccine against respiratory syncytial virus, Ebola or malaria.

How many employees does Novavax employ in its plant near Prague? Does it plan to hire more employees in the future?

Currently, the Czech production plant for Novavax employs 150 vaccine experts, but we plan to expand their team in the future. We are currently ready to put another 100 or more new employees into operation, both in the area of ​​the production of the vaccine itself and in the area of ​​disinfection of the plant premises or maintenance of production equipment.

The European Union is now negotiating agreements with potential manufacturers of coronavirus vaccine candidates, to be acceded to by the Member States. Is Novavax involved in these negotiations and how far are they?

As can be seen from some of the recent agreements, Novavax is already working with a number of countries to obtain vaccines for their people. We will continue to report on our further negotiations.  

600 Postings, 562 Tage BananiCorporate Overview and

 
  
    #333
10.09.20 19:35

600 Postings, 562 Tage BananiUpcoming Investor Conferences

 
  
    #334
14.09.20 18:52
Novavax to Participate in Upcoming Investor Conferences

Conference details are as follows:

Citi 15th Annual BioPharma Virtual Conference
Date: September 10, 2020

H.C. Wainwright 22nd Annual Global Investment Conference
Date: September 14, 2020
Time: 9:30 a.m. U.S. Eastern Time (ET)

Cantor Virtual Global Healthcare Conference
Date: September 15, 2020
Time: 11:20 a.m. U.S. Eastern Time (ET)

Morgan Stanley Virtual 18th Annual Global Healthcare Conference
Date: September 16, 2020
Time: 12:30 p.m. U.S. Eastern Time (ET)

Leerink CyberRx Series: Vaccine Forum
Date: September 23, 2020
Time: 9:00 a.m. U.S. Eastern Time (ET)

https://ir.novavax.com/news-releases/...upcoming-investor-conferences  

600 Postings, 562 Tage BananiConference (Transcript)

 
  
    #335
14.09.20 21:40
Novavax, Inc. (NVZAX) Management Presents at H.C. Wainwright 22nd Annual Global Investment Conference (Transcript)

https://seekingalpha.com/article/...nual-global-investment-conference  

600 Postings, 562 Tage BananiNews:

 
  
    #336
15.09.20 13:34
Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India, Increasing Novavax’ Global Production Capacity to Over 2 Billion Doses Annually

-Serum Institute of India to manufacture ~1 billion doses of NVX-CoV2373 in 2021

-Increases global manufacturing capacity for NVX-CoV2373 to over 2 billion annualized doses when at full capacity in 2021

-Agreement expands Novavax partnership with world’s largest vaccine developer to increase global delivery of NVX-CoV2373


https://ir.novavax.com/news-releases/...manufacturing-agreement-serum  

600 Postings, 562 Tage BananiEU News im Anmarsch

 
  
    #337
15.09.20 14:29
Cvirus.- Biofabri (Grupo Zendal) producirá en Europa la vacuna contra el Covid-19 de Novavax

... El grupo biofarmacéutico Zendal, a través de su filial Biofabri, ha sido el elegido por la compañía americana Novavax para la producción industrial de su vacuna contra el Covid-19, la enfermedad que provoca el nuevo coronavirus, en la Unión Europea....

... Der biopharmazeutische Konzern Zendal wurde über seine Tochtergesellschaft Biofabri von der amerikanischen Firma Novavax für die industrielle Herstellung seines Impfstoffs gegen Covid-19, die Krankheit, die das neue Coronavirus verursacht, in der Europäischen Union ausgewählt....


https://www.cope.es/actualidad/sociedad/noticias/...x-20200915_894719  

600 Postings, 562 Tage BananiLesenswert:

 
  
    #338
16.09.20 08:03
Novavax, Inc. (NVAX) Management Presents at Cantor Virtual Global Healthcare Conference (Transcript)

https://seekingalpha.com/article/...-healthcare-conference-transcript  

600 Postings, 562 Tage BananiLesenswert, die Zweite:

 
  
    #339
17.09.20 10:33
Novavax, Inc. (NVAX) Management Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)

https://seekingalpha.com/article/...nual-global-healthcare-conference  

600 Postings, 562 Tage BananiSehr gute Strategie seitens Novavax!

 
  
    #340
17.09.20 10:39
Die globale Produktionskapazität in großem Maßstab zu erweitern und das von Beginn an ist ein sehr wichtiger strategischer Schachzug, nur meine Meinung.


UN-Generalsekretär Guterres für 'Volksimpfstoff' gegen Corona

Wenige Tage vor der Generaldebatte der diesjährigen UN-Vollversammlung hat Generalsekretär António Guterres zum gemeinsamen Vorgehen bei der Entwicklung eines Impfstoffs gegen Covid-19 aufgerufen. "Wir brauchen einen Impfstoff, der erschwinglich und für alle verfügbar ist - einen Volksimpfstoff", sagte Guterres am Mittwoch in New York. Ein funktionierender Wirkstoff sei öffentliches Gut und dürfe nicht "nationalisiert" werden.

Guterres warb für die Initiative Covax der Weltgesundheitsorganisation WHO, die zu internationaler Zusammenarbeit bei der Herstellung eines Impfstoffs und gerechter Verteilung beitragen soll. Mehr als 170 Länder haben an dem Vorstoß UN-Angaben zufolge Interesse. Vor allem aber die USA gehen einen eigenen Weg.

https://app.handelsblatt.com/...t=ST-1523175-5alhKkohbfdO0kpaoByn-ap2  

600 Postings, 562 Tage BananiEU talks with Novavax

 
  
    #341
23.09.20 21:01

600 Postings, 562 Tage BananiNovavax Initiates Phase 3

 
  
    #342
25.09.20 06:23
Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom


https://ir.novavax.com/news-releases/...aVOsgmUq3C-29uqsihXnp1te1CDj0  

125 Postings, 224 Tage BabyfantDeshalb

 
  
    #343
25.09.20 08:03
der Anstieg?  

600 Postings, 562 Tage BananiWenn man es Anstieg nennen

 
  
    #344
25.09.20 09:28
kann. Im Moment sind sowieso die Swing Trader zugange, imo.  

600 Postings, 562 Tage BananiEndo Announces Fill-Finish Manufacturing

 
  
    #345
25.09.20 14:11
Endo Announces Fill-Finish Manufacturing and Services Agreement for Novavax COVID-19 Vaccine Candidate


https://www.prnewswire.com/news-releases/...n6nJv4pYfss2TnnGHYzmk7XAU  

600 Postings, 562 Tage BananiDie Werbetrommel wird kräftig gerührt

 
  
    #346
25.09.20 15:16

Seite: < 1 | 2 | 3 | 4 |
12 | 13 | 14 14  >  
   Antwort einfügen - nach oben